The main therapeutic groups of Grindeks are cardiovascular, central nervous system, anticancer and diabetes drugs. Starting from 2023, dermatology will also become one of the main therapeutic groups of Grindeks, due to the growing need of patients for modern medicines for skin diseases treatment.

In the world, the common understanding of skin diseases is increasing, that is, if they are professionally treated, then people’s health and quality of life improve significantly. Currently, Grindeks provides patients with the highest quality and efficiency ointments and gels for the skin diseases treatment, which are produced both in Latvia and Estonia.

The future of dermatology is a joint effort we are making now for a healthier tomorrow.